P-Synephrine stimulates glucose consumption via AMPK in L6 skeletal muscle cells

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 720-724

  Hong, Na Young ^a   Cui, Zhi Gang ^a   Kang, Hee Kyoung ^a   Lee, Dae Ho ^a   Lee, Young Ki ^a   Park, Deok Bae ^a  

^a Jeju National University School of Medicine   (South Korea)

Author keywords

AMPK; Glucose consumption; Glut4; P Synephrine

Indexed keywords

4 SYNEPHRINE; AMP STIMULATED PROTEIN KINASE; GLUCOSE TRANSPORTER 4; INSULIN; LACTIC ACID; OXEDRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE INTAKE; GLUCOSE TRANSPORT; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ADRENERGIC ALPHA-AGONISTS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; GLUCOSE; HUMANS; MUSCLE, SKELETAL; RATS; SYNEPHRINE;

CITRUS; CITRUS AURANTIUM;

EID: 84862786844     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.085     Document Type: Article

References (31)

1. Hallas J., Bjerrum L., Støvring H., Andersen M. Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study. Am. J. Epidemiol. 2008, 168:966-973.
2. Gregory P.J. Evaluation of the stimulant content of dietary supplements marketed as " ephedra-free" J. Herb. Pharmacother. 2007, 7:65-72.
3. Haaz S., Fontaine K.R., Cutter G., Limdi N., Perumean-Chaney S., Allison D.B. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes. Rev. 2006, 7:79-88.
4. Arbo M.D., Larentis E.R., Linck V.M., Aboy A.L., Pimentel A.L., Henriques A.T., Dallegrave E., Garcia S.C., Leal M.B., Limberger R.P. Concentrations of p-synephrine in fruits and leaves of citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food Chem. Toxicol. 2008, 46:2770-2775.
5. M. Blumenthal, Bitter orange peel and synephrine. Part 1. Whole Foods (2004) 77-79, pp. 97.
6. Stohs S.J., Shara M. A review of the safety and efficacy of Citrus aurantium in weight management. Obesity: Epidemiology, Pathophysiology, and Prevention 2007, 371-382. CRC Press, Boca Raton, FL. D. Bagchi, H.G. Preuss (Eds.).
7. Anon, Dangerous supplements. What you don't know about these 12 ingredients could hurt you. Consumer Reports, September 16-20, 2010.
8. Stohs S.J., Preuss H.G., Shara M. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Phytother. Res. 2011, 25:1421-1428.
9. Andrade A.S., Schmitt G.C., Rossato L.G., Russowsky D., Limberger R.P. Gas chromatographic method for analysis of p-synephrine in Citrus aurantium L. products. Chromatographia 2009, S225-S229.
10. Avula B., Upparapalli S.K., Navarrete A., Khan I.A. Simultaneous quantification of adrenergic amines and flavonoids in Citrus aurantium, various citrus species, and dietary supplements by liquid chromatography. J. AOAC. Int. 2005, 88:1593-1606.
11. Fugh-Berman A., Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp. Biol. Med. 2004, 229:698-704.
12. Rossato L.G., Costa V.M., Limberger R.P., Bastos Mde L., Remião E. Synephrine: from trace concentrations to massive consumption in weight-loss. Food Chem. Toxicol. 2011, 49:8-16.
13. Lawson M.A., Purslow P.P. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 2000, 167:130-137.
14. Yin J., Hu R., Chen M., Tang J., Li F., Yang Y., Chen J. Effects of berberine on glucose metabolism in vitro. Metabolism 2002, 51:1439-1443.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
16. Ma G., Bavadekar S.A., Schaneberg B.T., Khan I.A., Feller D.R. Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes. Planta Med. 2010, 76:981-986.
17. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 2007, 100:328-341.
18. Hwang S.L., Yang B.K., Lee J.Y., Kim J.H., Kim B.D., Suh K.H., Kim D.Y., Kim M.S., Song H., Park B.S., Huh T.L. Isodihydrocapsiate stimulates plasma glucose uptake by activation of AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2008, 371:289-293.
19. Breen D.M., Sanli T., Giacca A., Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem. Biophys. Res. Commun. 2008, 374:117-122.
20. Zygmunt K., Faubert B., MacNeil J., Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem. Biophys. Res. Commun. 2010, 398:178-183.
21. Yin J., Gao Z., Liu D., Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E148-E156.
22. Wu S.B., Wei Y.H. AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. Biochim. Biophys. Acta 1822, 2012:233-247.
23. Torp K.D., Tschakovsky M.E., Halliwill J.R., Minson C.T., Joyner M.J. beta-Receptor agonist activity of phenylephrine in the human forearm. J. Appl. Physiol. 2001, 90:1855-1859.
24. Arch J.R. Beta(3)-adrenoceptor agonists: potential, pitfalls and progress. Eur. J. Pharmacol. 2002, 440:99-107.
25. Tsujita T., Takaku T. Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark). J. Nutr. Sci. Vitaminol. (Tokyo) 2007, 53:547-551.
26. Chernogubova E., Cannon B., Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 2004, 145:269-280.
27. Nevzorova J., Evans B.A., Bengtsson T., Summers R.J. Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells. Brit. J. Pharmacol. 2006, 147:446-454.
28. de Souza C.J., Hirshman M.F., Horton E.S. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes 1997, 46:1257-1263.
29. Hutchinson D.S., Bengtsson T. Alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway. Endocrinology 2005, 146:901-912.
30. Hutchinson D.S., Bengtsson T. AMP-activated protein kinase activation by adrenoceptors in L6 skeletal muscle cells: mediation by alpha1-adrenoceptors causing glucose uptake. Diabetes 2006, 55:682-690.
31. Viollet B., Andreelli F. AMP-activated protein kinase and metabolic control. Handb. Exp. Pharmacol. 2011, 203:303-330.